Table 1.
Basic information of included patients
| Sample number | Age (years) | Ethnicity | Nationality | HPV type | Pathological type | Pathological type |
|---|---|---|---|---|---|---|
| H0360 | 49 | Han | China | 16 | HSIL | — |
| H0528 | 46 | Han | China | 16 | LSIL | — |
| H0517 | 52 | Han | China | 16 | HSIL | — |
| H0439 | 52 | Han | China | 16 | Cervical cancer | Squamous cell carcinoma |
| H0281 | 46 | Han | China | 16 | Cervical cancer | Squamous cell carcinoma |
| H0322 | 46 | Han | China | 16 | Cervical cancer | Adenocarcinoma |
| H0209 | 62 | Han | China | 52 | Cervical cancer | Squamous cell carcinoma |
| H0237 | 65 | Han | China | 58 | Cervical cancer | Squamous cell carcinoma |
| H0421 | 49 | Han | China | 39 | Cervical cancer | Squamous cell carcinoma |
| H0074 | 49 | Han | China | 16 | LSIL | — |
| H0076 | 32 | Han | China | 16 | HSIL | — |
| H0224 | 33 | Han | China | 16 | HSIL | — |
| H0507 | 50 | Han | China | 16 | Cervical cancer | Adenocarcinoma |
| H0284 | 60 | Han | China | 18 | Cervical cancer | Adenocarcinoma |
| H0240 | 63 | Han | China | 18 | Cervical cancer | Squamous cell carcinoma |
| H0042 | 43 | Han | China | 18 | HSIL | — |
| H0536 | 47 | Han | China | 16 | HSIL | — |
| H0206 | 37 | Han | China | 16 | HSIL | — |
| H0584 | 32 | Han | China | 16, 51 | HSIL | — |
| H0075 | 33 | Uighur | China | 16 | Cervical cancer | Squamous cell carcinoma |
| H0044 | 53 | Uighur | China | 58 | Cervical cancer | Squamous cell carcinoma |
| H0084 | 50 | Uighur | China | 53 | HSIL | — |
| H0083 | 43 | Uighur | China | 16 | Cervical cancer | Squamous cell carcinoma |
| H0402 | 36 | Uighur | China | 31 | HSIL | — |
| H0324 | 25 | Uighur | China | 18 | Cervical cancer | Squamous cell carcinoma |
| H0433 | 60 | Uighur | China | 16 | Cervical cancer | Adenocarcinoma |
| H0200 | 75 | Uighur | China | 16 | Cervical cancer | Squamous cell carcinoma |
| H0289 | 53 | Uighur | China | 18 | Cervical cancer | Squamous cell carcinoma |
| H0589 | 45 | Uighur | China | 16 | HSIL | — |
| H0604 | 45 | Uighur | China | 18 | Cervical cancer | Squamous cell carcinoma |
| H0030 | 58 | Uighur | China | 16 | Cervical cancer | Squamous cell carcinoma |
| H0455 | 48 | Uighur | China | 35 | HSIL | — |
| H0275 | 55 | Uighur | China | 18 | HSIL | — |
| H0521 | 55 | Uighur | China | 16 | Cervical cancer | Squamous cell carcinoma |
| H0041 | 47 | Uighur | China | 18 | HSIL | — |
| H0212 | 54 | Uighur | China | 16 | HSIL | — |
| H0203 | 68 | Uighur | China | 16 | Cervical cancer | Adenocarcinoma |
| H0208 | 41 | Uighur | China | 16 | Cervical cancer | Squamous cell carcinoma |
| H0595 | 40 | Uighur | China | 18 | HSIL | — |
| H0047 | 63 | Uighur | China | 31/51/52 | Cervical cancer | Squamous cell carcinoma |
| H0287 | 56 | Uighur | China | 18 | Cervical cancer | Squamous cell carcinoma |
| H0489 | 44 | Uighur | China | 16 | LSIL | — |
| H0235 | 55 | Uighur | China | 16 | HSIL | — |
| H0067 | 41 | Uighur | China | 16 | HSIL | — |
| H0390 | 33 | Uighur | China | 16 | LSIL | — |
| H0416 | 60 | Uighur | China | 16 | Cervical cancer | Squamous cell carcinoma |
| H0201 | 63 | Uighur | China | 16 | Cervical cancer | Squamous cell carcinoma |
| H0034 | 31 | Uighur | China | 16 | Cervical cancer | Adenocarcinoma |
| H0320 | 50 | Uighur | China | 18 | Cervical cancer | Adenocarcinoma |
| H0288 | 63 | Uighur | China | 16 | Cervical cancer | Squamous cell carcinoma |
| H0527 | 54 | Uighur | China | 18 | LSIL | — |
| H0593 | 36 | Uighur | China | 33 | Cervical cancer | Squamous cell carcinoma |
Note: HPV, human papillomavirus; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade intraepithelial lesion.